Cannitrol – Cannabis Control Agent

Marijuana news from around the world

United Kingdom

The CBD Regulatory Environment in Europe: Part 4

This is the final piece of a four-part series discussing European cannabis regulations. Click here for Part One, here for Part Two and here for Part Three. Part Four wraps up the series below.  Where is the future of CBD heading? A review of these various jurisdictions, the EU, the UK, and the USA, makes it clear that […]

, , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,

The CBD Regulatory Environment in Europe: Part 3

This is Part Three of a four-part series discussing European cannabis regulations. Click here for Part One and here for Part Two. Part Three dives into dosage, approvals and more. Stay tuned for the final Part Four, coming next week. But does CBD harm the liver? Here, it is important that we compare apples to apples. […]

, , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,

The CBD Regulatory Environment in Europe: Part 2

This is Part Two of a four-part series discussing European cannabis regulations. Click here for Part One. Part Two analyzes the differences between the UK, the EU and the US. Part Three, coming next week, dives into dosage, approvals and more. Stay tuned for more. EU Regulatory Environment We Europeans look with envy at the […]

, , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,

The CBD Regulatory Environment in Europe: Part 1

This is Part One of a four-part series discussing European cannabis regulations. Part One serves as an introduction. Part Two, coming next week, will analyze the differences between the UK, the EU and the US. Stay tuned for more. As I walk through any European cannabis expo – events like Cultiva Hanfexpo, Cannafest Prague or […]

, , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,

New Study Highlights Marijuana Benefits for Patients with MS

ms research

The wonder plant marijuana is showing off its medical diversity again.  Research has been discovering many potential medical uses for marijuana.  This week a new research study has uncovered even more evidence that marijuana can be beneficial to a wide variety of ailments, including multiple sclerosis.

Researchers in the United Kingdom analyzed the results of over 300 participants across 22 medical facilities who were suffering from MS.  The study was aimed specifically at relieving muscle stiffness, which impacts approximately 90% of those who have MS.  The effects of MS are well documented and many who have it find themselves having trouble with mobility and leading their daily lives.  Sleep deprivation is also commonly associated with MS and muscle stiffness.

The study results may give new hope for patients with MS who have not been responsive to traditional treatments.  In the UK study, which will be published in the Journal of Neurology, Neurosurgery and Psychiatry, researchers gave one group of participants marijuana while giving another group placebo.  After 12 weeks, 30 percent of those who were given marijuana reported improvements in pain and mobility.  Only 16% of the placebo group reported improvements.  The known side effects of marijuana, dizziness, confusion, fatigue etc. have been previously reported as negative side effects in past marijuana/MS studies.  While those still occurred study researchers announced “No new safety concerns were observed.”

Treatments for Multiple Sclerosis, like many, have eluded scientists for decades.  However, marijuana breakthroughs have been occurring regularly in recently with scientists also discovering that cannabis may be able to stop the metastasis of cancer, the spreading of HIV/AIDS, and many other difficult to treat conditions.  The hope now is that mainstream media outlets and political leaders keep the issue on the forefront.

, , , , , , , , , , ,